The Latin America, Middle East and Africa Molecular Quality Controls Market would witness Market growth of 9.5% CAGR during the forecast period (2022-2028).
Molecular quality control seeks to identify problems in molecular diagnostic products and report them to management, affecting the decision on whether or not to release the product. Quality control procedures for molecular testing have become increasingly popular in recent years, especially for infectious disease tests, where quality control materials are readily available, tests are declared clear by the FDA, published quality control guidelines are available, and the tests are quantitative with a limited number of analytes. For some multiplex tests, such as the cystic fibrosis test, quality controls are also provided.
According to WHO studies, 7% of the global population carries the genes for hemoglobin disorders like sickle cell disease and thalassemia. As a result of the rising occurrence of such inherited illnesses, the necessity for molecular quality controls is growing in the region. A key driver of the Molecular Quality Control industry is the government's initiatives to promote clinical research. Product launches and permissions are the most popular ways for businesses to grow their global footprints and product lines. The expansion of the molecular quality controls Market can be attributed to increase funding for genomics, lower sequencing costs, and the rising prevalence of genetic diseases.
The molecular quality controls Market in LAMEA will grow in the future due to an increase in the incidence of infectious diseases, government attention on quality control in the pharmaceutical industry, and important firms' focus on grabbing opportunities in emerging countries. The rise of the molecular control Market in the region is due to an increase in the number of QC molecular labs. The Middle East and Africa (MEA), are developing as well, and are projected to overcome the effects of the covid-19 in the upcoming years.
The Brazil Market dominated the LAMEA Molecular Quality Controls Market by Country 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $4.3 million by 2028. The Argentina Market is poised to grow at a CAGR of 10% during (2022 - 2028). Additionally, The UAE Market would experience a CAGR of 9.2% during (2022 - 2028).
Based on Analyte Type, the Market is segmented into Single-analyte Controls and Multi-analyte Controls. Based on Application, the Market is segmented into Infectious Diseases Diagnostics, Oncology Testing, Genetic Testing, and Others. Based on Product, the Market is segmented into Independent Controls and Instrument-specific Controls (PCR, DNA Sequencing & NGS, and Others). Based on End User, the Market is segmented into Diagnostic Laboratories, Hospitals, IVD Manufacturers & CROs, Academic & Research Institutes, and Others. Based on countries, the Market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Molecular Quality Controls Market is Predict to reach $259.4 Million by 2028, at a CAGR of 6.6%
The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include Grifols, S.A, Abbott Laboratories, Quidel Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Seegene, Inc., Randox Laboratories Limited, F. Hoffmann-La Roche Ltd., Bio-Techne Corporation, and Microbiologics, Inc.
By Analyte Type
By Application
By Product
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 